BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2237567)

  • 1. Hypercalcemia as a clinical prodrome to lymphoma.
    Krolick MA; Altus P; Foulis PR
    South Med J; 1990 Nov; 83(11):1331-4. PubMed ID: 2237567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
    Santhosh-Kumar CR; Ajarim DS; Shipkey FD
    Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
    Bartlett NL; Petroni GR; Parker BA; Wagner ND; Gockerman JP; Omura GA; Canellos GP; Robert M; Johnson JL; Peterson BA
    Cancer; 2001 Jul; 92(2):207-17. PubMed ID: 11466671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia.
    Takasaki H; Kanamori H; Takabayashi M; Yamaji S; Koharazawa H; Taguchi J; Fujimaki K; Ishigatsubo Y
    Am J Hematol; 2006 Jun; 81(6):439-42. PubMed ID: 16680736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of invasive non-Hodgkin's lymphoma].
    Yu H; Hong XN; Li J; Peng LP; Ye L
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of non-Hodgkin's lymphoma in a patient with common variable immunodeficiency.
    Ohnoshi T; Hayashi K; Tagawa S; Saito S; Matsutomo S; Kawashima K; Kimura I
    Intern Med; 1993 Feb; 32(2):152-5. PubMed ID: 7685210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 78-year-old women with hypercalcemia now and malignancy of unknown origin 11 years ago.
    Royen HI; Westedt ML; den Ottolander GJ; Bieger R
    Ann Hematol; 1998 Feb; 76(2):95-8. PubMed ID: 9540767
    [No Abstract]   [Full Text] [Related]  

  • 9. The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
    Lishner M; Slingerland J; Theresa C; Sutcliffe SB
    Leuk Lymphoma; 1994 Mar; 13(1-2):131-6. PubMed ID: 7517744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
    Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.
    Shipp MA; Neuberg D; Janicek M; Canellos GP; Shulman LN
    J Clin Oncol; 1995 Dec; 13(12):2916-23. PubMed ID: 8523055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
    Gottlieb AJ; Anderson JR; Ginsberg SJ; Bloomfield CD; Norton L; Barcos M; Peterson BA; Nissen N; Henderson ES; Holland JF
    Cancer; 1990 Nov; 66(9):1888-96. PubMed ID: 1699653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases].
    Huang S; Zheng ZX; Xu Q; Yuan XH
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):305-8. PubMed ID: 23985262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
    Coiffier B; Reyes F;
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):7-15. PubMed ID: 15934513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
    Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
    Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
    Czuczman MS
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravascular B-cell lymphoma with hypercalcemia as the initial presentation.
    Chinen Y; Nakao M; Sugitani-Yamamoto M; Kiyota M; Horiike S; Kuroda J; Taniwaki M
    Int J Hematol; 2011 Dec; 94(6):567-70. PubMed ID: 22045306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review.
    Shallis RM; Rome RS; Reagan JL
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e123-e129. PubMed ID: 29361495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.